Author

U. Cavallaro

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

N. Colombo· 3 shared C. Battistini· 2 shared F. Bianchi· 2 shared M. Lupia· 2 shared V. Melocchi· 2 shared V. Nieddu· 2 shared A. Decio· 1 shared A. Garbi· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

N. Colombo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness

C. Battistini, H. A. Kenny, V. Nieddu, V. Melocchi, A. Decio, A. Gatto, M. Ghioni, F. M. Porta, R. Giavazzi, N. Colombo, F. Bianchi, E. Lengyel, U. Cavallaro

This study identifies FOXM1 as a microenvironment-induced factor that sustains ovarian cancer stemness and enhances response to Olaparib.

bioRxiv · Oct 30, 2023 · PreprintCancer Biology

Matrix Gla Protein acts as a driver of stemness and tumor initiation in ovarian cancer

V. Nieddu, V. Melocchi, C. Battistini, G. Franciosa, M. Lupia, C. Stellato, G. Bertalot, J. V. Olsen, N. Colombo, F. Bianchi, U. Cavallaro

This study identifies Matrix Gla Protein (MGP) as a driver of stemness and tumor initiation in ovarian cancer by promoting Hedgehog signaling and enhancing tumor-initiating capacity.

Cell Death & Disease · Mar 28, 2023Peer-reviewedCancer Biology

A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high grade serous ovarian cancer

P. Lo Riso, C. E. Villa, G. Gasparoni, R. Luongo, A. Manfredi, A. Vingiani, A. Jungmann, A. Garbi, M. Lupia, P. Laise, V. Das, G. Pruneri, G. Viale, N. Colombo, U. Cavallaro, , G. Testa

This study identifies DNA methylation differences between fimbrial and ovarian surface epithelia to create an epigenetic tracer that stratifies high grade serous ovarian cancer into clinically distinct subtypes with prognostic significance.

bioRxiv · Nov 30, 2018Cancer Biology